The potential contribution of XRCC3 rs861539 to cancer susceptibility has been widely addressed: while conflicting evidence exists, several large meta-analyses strongly support a positive association with cancer susceptibility, namely breast [34,35,36] and bladder cancer [36,37,38], among others. This evidence concerns the gene XRCC3 and urinary bladder carcinoma.